Strategic EP, LLC Reports No Beneficial Ownership in Alaunos Therapeutics, Inc.

Strategic EP, LLC has filed an amendment to its Schedule 13G with the SEC, reporting that it no longer holds any beneficial ownership in Alaunos Therapeutics, Inc. The filing indicates that Strategic EP, LLC has 0 shares of common stock in Alaunos Therapeutics, Inc., with no voting or dispositive power. The filing is made under Rule 13d-1(c) and certifies that the securities were not acquired for the purpose of influencing the control of the issuer. The amendment is dated October 16, 2025, and is signed by Alexander Chase Deitch, Manager of Strategic EP, LLC.